Global Health Complications of Obesity presents a valuable resource for research scientists and clinicians by covering the burden of obesity and related diseases and serving as a starting point for in-depth discussions in academic settings and for obesity-treatment specialists. Obesity is associated with a statistically higher risk of heart disease, hypertension, insulin resistance, type 2 diabetes and many other diseases. This succinct resource focuses on the current data, research and management of obesity. It is essential reading for healthcare professionals, endocrinologists, nutritionists, public health students and medical students.
- Presents clinical cases, key terms and targeted references
- Addresses diseases including diabetes, cancer, hypertension, osteoarthritis, fatty liver disease, infertility, renal failure and depression
- Provides a link to new knowledge that is ideal for both researchers and clinicians
About the authors |
|
xi | |
Preface |
|
xiii | |
Acknowledgment |
|
xv | |
|
|
|
|
1 | (1) |
|
Definition and measurement |
|
|
1 | (2) |
|
|
3 | (3) |
|
Etiology and risk factors |
|
|
6 | (4) |
|
Health consequences of childhood obesity |
|
|
10 | (1) |
|
|
11 | (1) |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (2) |
|
2 Obesity and total mortality |
|
|
|
|
17 | (1) |
|
Global prevalence of adult obesity |
|
|
17 | (2) |
|
Prevalence of adult obesity in the United States |
|
|
19 | (1) |
|
Morbidity and mortality statistics |
|
|
19 | (2) |
|
Gender differences in obesity |
|
|
21 | (1) |
|
Urban versus rural differences in obesity |
|
|
21 | (1) |
|
Distribution of obesity by age, gender, and ethnicity in the United States |
|
|
21 | (1) |
|
|
22 | (1) |
|
Economics, culture, and religion |
|
|
23 | (1) |
|
Obesity and quality of life |
|
|
24 | (1) |
|
|
25 | (2) |
|
|
27 | (1) |
|
|
27 | (2) |
|
3 Risk factors of obesity |
|
|
|
|
29 | (1) |
|
|
29 | (1) |
|
Environmental factors contributing to obesity |
|
|
30 | (1) |
|
|
31 | (1) |
|
Risk factors in early life and the development of later obesity |
|
|
32 | (1) |
|
Early adiposity rebound and future health risks |
|
|
32 | (1) |
|
Health consequences of childhood obesity |
|
|
32 | (1) |
|
|
32 | (1) |
|
Stress and mental illness |
|
|
32 | (3) |
|
Low socioeconomic status and obesity |
|
|
35 | (1) |
|
|
36 | (3) |
|
|
39 | (1) |
|
|
39 | (2) |
|
4 Cardiovascular disease and its risk factors |
|
|
|
|
41 | (1) |
|
|
41 | (4) |
|
|
45 | (6) |
|
|
51 | (5) |
|
|
56 | (4) |
|
|
60 | (4) |
|
|
64 | (4) |
|
|
68 | (5) |
|
|
73 | (4) |
|
|
77 | (2) |
|
|
79 | (2) |
|
5 Disorders of insulin regulation |
|
|
|
|
81 | (1) |
|
|
81 | (1) |
|
|
82 | (20) |
|
|
102 | (3) |
|
|
105 | (2) |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
|
|
109 | (1) |
|
|
109 | (6) |
|
|
115 | (4) |
|
|
119 | (10) |
|
|
129 | (3) |
|
|
132 | (2) |
|
|
134 | (3) |
|
|
137 | (5) |
|
|
142 | (2) |
|
|
144 | (1) |
|
|
145 | (2) |
|
|
|
|
147 | (1) |
|
|
147 | (6) |
|
Restrictive lung function |
|
|
153 | (7) |
|
|
160 | (2) |
|
Chronic obstructive pulmonary disease |
|
|
162 | (4) |
|
Complications during general anesthesia |
|
|
166 | (1) |
|
|
167 | (4) |
|
|
171 | (1) |
|
|
172 | (1) |
|
8 Joint and connective tissue disorders |
|
|
|
|
173 | (1) |
|
|
173 | (7) |
|
|
180 | (7) |
|
|
187 | (5) |
|
|
192 | (4) |
|
Connective tissue disorders |
|
|
196 | (1) |
|
|
197 | (2) |
|
|
199 | (1) |
|
|
200 | (3) |
|
9 Gastrointestinal problems |
|
|
|
|
203 | (1) |
|
Gastroesophageal reflux disease |
|
|
203 | (2) |
|
|
205 | (3) |
|
|
208 | (5) |
|
|
213 | (4) |
|
|
217 | (3) |
|
|
220 | (1) |
|
|
221 | (2) |
|
|
|
|
223 | (1) |
|
|
223 | (12) |
|
|
235 | (3) |
|
|
238 | (10) |
|
Polycystic ovary syndrome |
|
|
248 | (4) |
|
|
252 | (2) |
|
|
254 | (1) |
|
|
255 | (2) |
|
|
|
|
257 | (1) |
|
|
257 | (8) |
|
|
265 | (1) |
|
|
266 | (8) |
|
|
274 | (3) |
|
|
277 | (7) |
|
|
284 | (3) |
|
|
287 | (1) |
|
|
288 | (1) |
|
|
|
|
289 | (1) |
|
Increased sweat and skin secretions |
|
|
289 | (2) |
|
|
291 | (6) |
|
|
297 | (4) |
|
|
301 | (4) |
|
|
305 | (2) |
|
|
307 | (2) |
|
|
309 | (4) |
|
|
313 | (1) |
|
|
314 | (1) |
|
13 Social and psychological problems |
|
|
|
|
315 | (1) |
|
|
315 | (11) |
|
|
326 | (1) |
|
|
327 | (1) |
|
Decreased work productivity |
|
|
328 | (1) |
|
Biases in the workplace or society |
|
|
329 | (2) |
|
|
331 | (4) |
|
|
335 | (1) |
|
|
335 | (2) |
|
|
|
|
337 | (1) |
|
|
337 | (7) |
|
The burden of childhood obesity |
|
|
344 | (2) |
|
|
346 | (4) |
|
|
350 | (1) |
|
|
351 | (1) |
|
|
351 | (2) |
|
15 Obesity in the elderly |
|
|
|
|
353 | (1) |
|
|
353 | (3) |
|
Overnutrition in the elderly |
|
|
356 | (1) |
|
|
356 | (2) |
|
Cardiovascular disease and obesity in the elderly |
|
|
358 | (1) |
|
Drug and nutrient interactions in elderly |
|
|
359 | (1) |
|
|
360 | (2) |
|
Prevention of obesity in the elderly |
|
|
362 | (1) |
|
|
363 | (3) |
|
|
366 | (1) |
|
|
366 | (3) |
|
|
|
|
369 | (1) |
|
Regular physical activity |
|
|
369 | (3) |
|
|
372 | (5) |
|
Gut microbiota and obesity |
|
|
377 | (1) |
|
|
377 | (2) |
|
|
379 | (2) |
|
|
381 | (1) |
|
Moderation of alcohol intake |
|
|
381 | (1) |
|
|
382 | (3) |
|
|
385 | (1) |
|
|
385 | (2) |
|
|
|
|
387 | (1) |
|
|
387 | (4) |
|
|
391 | (4) |
|
|
395 | (2) |
|
|
397 | (3) |
|
|
400 | (6) |
|
|
406 | (3) |
|
|
409 | (1) |
|
|
409 | (2) |
|
18 Perspective on economics and obesity |
|
|
|
|
411 | (1) |
|
Global burden of adult obesity |
|
|
411 | (2) |
|
Comparative analysis of major complications |
|
|
413 | (5) |
|
Health-care productivity and costs |
|
|
418 | (4) |
|
|
422 | (1) |
|
|
422 | (3) |
Glossary |
|
425 | (22) |
Index |
|
447 | |
Dr. Moini is an international author of 38 medical textbooks for various publishers including Elsevier, McGraw-Hill, Pearson, Jones & Bartlett Learning, Cengage Learning, and Routledge. In addition to continuing his venture as an author, he has been a professor for over 40 years. He is a retired professor with the Eastern Florida State College Science & Health Department. Previously, Dr. Moini was an assistant professor at Tehran University Medical School, Department of Epidemiology and Preventive Medicine. For 18 years, he was the Director of Epidemiology for the Brevard County Health Department. He was also Director of Allied Health at Everest University for 15 years. Dr. Ahangari is an Associate Professor in the Burnett School of Biomedical Sciences (BSBS) at the University of Central Florida (UCF) College of Medicine, teaching Human Physiology, Clinical Embryology and Clinical Endocrinology at undergraduate and graduate levels. She received her Doctor of Medicine (MD) degree from Carol Davila Medical University, Bucharest, Romania and completed her graduate neuroscience courses in the department of Cell Biology and Pathology in the Faculty of Medicine in the University of Salamanca. She received an Assistant Professor position in Anatomy at Saba University School of Medicine, Saba, Netherlands-Antilles in 2003. She joined the BSBS and Dr. H. Daniels lab in 2005, looking for the therapeutic effects of oral delivery of pro-insulin conjugated to cholera toxin-B subunit produced in tobacco and lettuce fed to diabetic mice (2005-2006). Dr. Ahangari is a graduate faculty scholar and she has directed several master capstone projects, undergraduate honors in major and independent studies in endocrine and metabolic disorders. Dr. Miller is an assistant professor and Director of the Clinical Performance Laboratory at Seattle University-College of Nursing. She received her PhD from Washington State University in 2014, Master in Nursing Education in 2006 from University of Phoenix, and BSN from Oregon Health Sciences University in 1991. Her nursing career has spanned 28 years with experience in labor and delivery, long-term care, operating room, lactation consulting, and dialysis. In addition, she is active in research and scholarly activities with publications and research projects surrounding lactation science. She currently resides in Seattle, Washington. Dr. Mohtashem Samsam is a former Professor of Medicine and a faculty at the Burnett School of Biomedical Sciences and College of Medicine at the University of Central Florida. He is currently the director and also a professor at Advent Health University in Orlando, Florida. Dr. Samsam studied medicine in the English language program of Albert Szent-Gyorgyi Medical University, in Szeged, Hungary (1991- 1996) and received his PhD from Department of Cell Biology and Pathology, Faculty of Medicine, University of Salamanca, Spain, in 2002. He completed his post-doc studies in Wuerzburg University, Germany (1999- 2002).